dose 0

DIETARY_SUPPLEMENT2 trials

Sponsors

Cr2o B.V., Pennington Biomedical Research Center

Conditions

COVID-19 and fluDiabetes Prevention

Phase 1

Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)

CompletedNCT02088203

Pennington Biomedical Research CenterDiabetes Prevention

Start: 2014-02-28End: 2018-05-31Updated: 2019-03-21

Phase 2

CONCOMITANT ADMINISTRATION OF LICENSED VACCINES AGAINST COVID-19 AND FLU WITH OR WITHOUT MF59 ADJUVANT: A MULTI-CENTRE, RANDOMIZED, SINGLE-BLIND CLINICAL TRIAL TO ASSESS IMMUNOGENICITY IN ADULTS AGED 65 AND OVER

CompletedCTIS2024-514798-23-00

Cr2o B.V.COVID-19 and flu

Start: 2024-10-02End: 2025-03-04Target: 120Updated: 2024-10-14